Youngblood develops antimicrobial surface technology
New technology, marketed commercially as Nouvex, and developed by Professor Jeffrey Youngblood, changes the composition of injected-molded products, giving them the ability to destroy pathogens on contact. We hope this partnership and technology take off. It is really timely during the current pandemic.
Learn more: bit.ly/Youngblood_Nouvex